Lantus is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Dispensing Solutions, Inc.. The primary component is Insulin Glargine.
Product ID | 55045-3685_71907ed5-ee95-471a-8d7d-f72dcbbdfb60 |
NDC | 55045-3685 |
Product Type | Human Prescription Drug |
Proprietary Name | Lantus |
Generic Name | Insulin Glargine |
Dosage Form | Injection, Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2009-09-23 |
Marketing Category | NDA / NDA |
Application Number | NDA021081 |
Labeler Name | Dispensing Solutions, Inc. |
Substance Name | INSULIN GLARGINE |
Active Ingredient Strength | 100 [iU]/mL |
Pharm Classes | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |
Marketing Start Date | 2009-09-23 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021081 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2009-09-23 |
Inactivation Date | 2019-10-29 |
Ingredient | Strength |
---|---|
INSULIN GLARGINE | 100 [iU]/mL |
SPL SET ID: | f2149727-c2df-41b0-97f1-45ea75e0aa1a |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
PHarm Class EPC | |
NUI Code |
NDC | Brand Name | Generic Name |
---|---|---|
0088-2220 | Lantus | insulin glargine |
70518-1865 | Lantus | Lantus |
0088-5021 | Lantus | Lantus |
50090-0876 | Lantus | Lantus |
55045-3685 | Lantus | Lantus |
64725-2220 | Lantus | Lantus |
0002-7715 | BASAGLAR | Insulin glargine |
0002-8214 | BASAGLAR | Insulin glargine |
0088-2219 | Lantus Solostar | insulin glargine |
0024-5869 | TOUJEO | insulin glargine |
0024-5871 | TOUJEO Max | insulin glargine |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
LANTUS 87583887 not registered Live/Pending |
SIG SAUER Inc. 2017-08-25 |
LANTUS 74436868 2183182 Live/Registered |
SANOFI-AVENTIS DEUTSCHLAND GMBH 1993-09-17 |